Common Stock, Shares, Outstanding of Terns Pharmaceuticals, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Terns Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2025.
  • Terns Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 87.5M shares, a 3.06% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)

Terns Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 87.5M +2.59M +3.06% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 87.5M +17.1M +24.4% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 87.3M +22.6M +35% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 87.1M +22.5M +34.9% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 84.9M +23.1M +37.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 70.3M +9.27M +15.2% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 64.7M +7.98M +14.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 64.6M +10.9M +20.2% Dec 31, 2023 10-K 2025-03-20
Q3 2023 61.8M +24.2M +64.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 61.1M +35.7M +141% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 56.7M +31.4M +124% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 53.7M +28.5M +113% Dec 31, 2022 10-K 2024-03-14
Q3 2022 37.6M +12.3M +48.9% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 25.4M +233K +0.93% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 25.3M +228K +0.91% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 25.3M +24.9M +7387% Dec 31, 2021 10-K 2023-03-27
Q3 2021 25.3M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 25.1M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 25M Mar 31, 2021 10-Q 2021-05-14
Q4 2020 338K Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.